Search Results - "El‐Serag, H."

Refine Results
  1. 1

    Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies by ElSerag, H., Becher, A., Jones, R.

    Published in Alimentary pharmacology & therapeutics (01-09-2010)
    “…Summary Background  Persistent gastro‐oesophageal reflux disease (GERD) symptoms can occur despite proton pump inhibitor (PPI) therapy. Aim  To assess the…”
    Get full text
    Journal Article
  2. 2

    Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agents by Lin, M., Kramer, J., White, D., Cao, Y., Tavakoli‐Tabasi, S., Madu, S., Smith, D., Asch, S. M., ElSerag, H. B., Kanwal, F.

    Published in Alimentary pharmacology & therapeutics (01-11-2017)
    “…Summary Background Direct‐acting anti‐virals (DAA) are safe, effective treatment of hepatitis C virus (HCV). Suboptimal linkage to specialists and access to…”
    Get full text
    Journal Article
  3. 3

    Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case‐control study in US male veterans by Tan, M. C., ElSerag, H. B., Yu, X., Thrift, A. P.

    Published in Alimentary pharmacology & therapeutics (01-08-2018)
    “…Summary Background Proton pump inhibitors (PPIs) and histamine‐2 receptor antagonists (H2RAs) may reduce the risk of oesophageal adenocarcinoma (OAC) in…”
    Get full text
    Journal Article
  4. 4

    Systematic review: the global incidence and prevalence of peptic ulcer disease by SUNG, J. J. Y., KUIPERS, E. J., ELSERAG, H. B.

    Published in Alimentary pharmacology & therapeutics (01-05-2009)
    “…Summary Background  Peptic ulcer disease (PUD) is most commonly associated with Helicobacter pylori infection and the use of acetylsalicylic acid (ASA) and…”
    Get full text
    Journal Article
  5. 5

    Systematic review: the association between symptomatic response to proton pump inhibitors and health‐related quality of life in patients with gastro‐oesophageal reflux disease by Becher, A., ElSerag, H.

    Published in Alimentary pharmacology & therapeutics (01-09-2011)
    “…Aliment Pharmacol Ther 2011; 34: 618–627 Summary Background  Some patients with gastro‐oesophageal reflux disease (GERD) experience persistent reflux symptoms…”
    Get full text
    Journal Article
  6. 6

    The association between gastro-oesophageal reflux disease and asthma: a systematic review by Havemann, B D, Henderson, C A, El-Serag, H B

    Published in Gut (01-12-2007)
    “…Background and aim:Gastro-oesophageal reflux disease (GORD) has been linked to a number of extra-esophageal symptoms and disorders, primarily in the…”
    Get full text
    Journal Article
  7. 7

    The impact of hepatitis C burden: an evidence‐based approach by Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., ElSerag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., Gordon, S. C.

    Published in Alimentary pharmacology & therapeutics (01-03-2014)
    “…Summary Background Infection with the hepatitis C virus (HCV) has been considered a major cause of mortality, morbidity and resource utilisation in the US. In…”
    Get full text
    Journal Article
  8. 8

    Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer by Walker, M., ElSerag, H. B., Sada, Y., Mittal, S., Ying, J., Duan, Z., Richardson, P., Davila, J. A., Kanwal, F.

    Published in Alimentary pharmacology & therapeutics (01-03-2016)
    “…Summary Background Most clinical practice guidelines recommend screening for HCC in patients with cirrhosis. However, patients with compensated cirrhosis are…”
    Get full text
    Journal Article
  9. 9

    Real‐world effectiveness of elbasvir/grazoprevir In HCV‐infected patients in the US veterans affairs healthcare system by Kramer, J. R., Puenpatom, A., Erickson, K. F., Cao, Y., Smith, D., ElSerag, H. B., Kanwal, F.

    Published in Journal of viral hepatitis (01-11-2018)
    “…Summary Elbasvir/grazoprevir (EBR/GZR) is an all‐oral direct‐acting antiviral agent (DAA) with high sustained virologic response (SVR) in clinical trials. This…”
    Get full text
    Journal Article
  10. 10

    Sleep duration and incidence of colorectal cancer in postmenopausal women by Jiao, L, Duan, Z, Sangi-Haghpeykar, H, Hale, L, White, D L, El-Serag, H B

    Published in British journal of cancer (15-01-2013)
    “…Background: Sleep duration is dependent on circadian rhythm that controls a variety of key cellular functions. Circadian disruption has been implicated in…”
    Get full text
    Journal Article
  11. 11

    Review article: current treatment options and management of functional dyspepsia by Lacy, B. E., Talley, N. J., Locke III, G. R., Bouras, E. P., DiBaise, J. K., El-Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., Prather, C.

    Published in Alimentary pharmacology & therapeutics (01-07-2012)
    “…Summary Background Functional dyspepsia (FD), a common functional gastrointestinal disorder, is defined by the Rome III criteria as symptoms of epigastric pain…”
    Get full text
    Journal Article
  12. 12

    Epidemiology and outcomes of hepatitis C infection in elderly US Veterans by El-Serag, H. B., Kramer, J., Duan, Z., Kanwal, F.

    Published in Journal of viral hepatitis (01-09-2016)
    “…Summary The chronic hepatitis C (CHC) cohort in the United States is getting older. Elderly patients with CHC may be at a high risk of cirrhosis and…”
    Get full text
    Journal Article
  13. 13

    Editorial: NAFLD‐related hepatocellular carcinoma ‐ increasing or not? With or without cirrhosis? by Balakrishnan, M., ElSerag, H. B.

    Published in Alimentary pharmacology & therapeutics (01-02-2018)
    “…Linked Content This article is linked to Pais et al paper. To view this article visit https://doi.org/10.1111/apt.14261…”
    Get full text
    Journal Article
  14. 14

    Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study by Davila, J A, Morgan, R O, Shaib, Y, McGlynn, K A, El-Serag, H B

    Published in Gut (01-04-2005)
    “…Background: Diabetes has been associated with an increased risk of hepatocellular carcinoma (HCC) in studies of referred patients. This is the first population…”
    Get full text
    Journal Article
  15. 15

    Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers by El-Serag, H B, Satia, J A, Rabeneck, L

    Published in Gut (01-01-2005)
    “…Background: Although diet has been associated with gastro-oesophageal reflux disease (GORD), the role of dietary components (total energy, macro and…”
    Get full text
    Journal Article
  16. 16

    Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma by Nordenstedt, H, Mattsson, F, El-Serag, H, Lagergren, J

    Published in British journal of cancer (28-02-2012)
    “…Background: Cholangiocarcinomas are highly lethal tumours of the intrahepatic or extrahepatic biliary tract. The aetiology is largely unknown, and the…”
    Get full text
    Journal Article
  17. 17

    The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases by KRAMER, J. R., DAVILA, J. A., MILLER, E. D., RICHARDSON, P., GIORDANO, T. P., ELSERAG, H. B.

    Published in Alimentary pharmacology & therapeutics (01-02-2008)
    “…Summary Background  The validity of International Classification of Diseases‐9 codes for liver disease has not been determined. Aim  To examine the accuracy of…”
    Get full text
    Journal Article
  18. 18

    Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data by Husain, N., Blais, P., Kramer, J., Kowalkowski, M., Richardson, P., ElSerag, H. B., Kanwal, F.

    Published in Alimentary pharmacology & therapeutics (01-10-2014)
    “…Summary Background In practice, nonalcoholic fatty liver disease (NAFLD) is diagnosed based on elevated liver enzymes and confirmatory liver biopsy or…”
    Get full text
    Journal Article
  19. 19

    Systematic review: the epidemiology of eosinophilic oesophagitis in adults by Sealock, R. J., Rendon, G., ElSerag, H. B.

    Published in Alimentary pharmacology & therapeutics (01-09-2010)
    “…Summary Background  The epidemiology of eosinophilic oesophagitis (EoE) in adults remains unclear. Aim  To estimate the prevalence and incidence of EoE through…”
    Get full text
    Journal Article
  20. 20

    Health‐related quality of life among persons with irritable bowel syndrome: a systematic review by ElSerag, H. B., Olden, K., Bjorkman, D.

    Published in Alimentary pharmacology & therapeutics (01-06-2002)
    “…Summary Aim : To perform a systematic review of the literature with three objectives: (1) to compare the health related quality of life (HRQoL) of patients…”
    Get full text
    Journal Article